Release Date: 21/02/18 08:25 Summary: Appointment of Chief Operating Officer Price Sensitive: No Download Document 562.72KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%